TY  - JOUR 
AU  - Sanz-Solas, Antonio
AU  - Labrador, Jorge
AU  - Alcaraz, Raquel
AU  - Cuevas, Beatriz
AU  - Vinuesa, Raquel
AU  - Cuevas, María Victoria
AU  - Saiz-Rodríguez, Miriam
PY  - 2023
SN  - 2075-4426
UR  - https://hdl.handle.net/10259/11919
AB  - Multiple myeloma (MM) is a hematological neoplasm for which different chemotherapy treatments are used with several drugs in combination. One of the most frequently used drugs for the treatment of MM is the proteasome inhibitor bortezomib. Patients...
LA  - eng
PB  - MDPI
KW  - Multiple myeloma
KW  - Bortezomib
KW  - Toxicity
KW  - Efficacy
KW  - Pharmacogenetic biomarkers
KW  - Farmacogenómica
KW  - Pharmacogenomics
TI  - Bortezomib Pharmacogenetic Biomarkers for the Treatment of Multiple Myeloma: Review and Future Perspectives
DO  - 10.3390/jpm13040695
T2  - Journal of Personalized Medicine
VL  - 13
ER  -